Product Details
Triumeq##
Dolutegravir (Dolutegravir Sodium); Abacavir; Lamivudine50 mg; 600 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
Glaxo Smithkline Consumer Nigeria PLC
NRN
B4-8285
Status
Active
Composition
Each film coated tablet contains: Dolutegravir 50 mg as Dolutegravir Sodium, Abacavir 600 mg as Abacavir Sulfate, Lamivudine 300 mg Excipients q.s.
ATC Code
J05AR13
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 30's (in HDPE bottle)
Product Description
Tablet Purple, biconvex, oval tablets debossed with "572 Trı" on one side TRIUMEQ DOLUTEGRAVIR/ABACAVIR/LAMIVUDINE 50 mg of dolutegravir as dolutegravir sodium, 600 mg of abacavir as abacavir sulfate and 300 mg of lamivudine B4-8285 Drugs Imported Products 1*30tablets POM 1 30/01/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 delphine.u.onyeaso@gsk.com GLAXO OPERATIONS UK LTD , PRIORY STREET ,WARE HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM . , GLAXO OPERATIONS UK LTD , PRIORY STREET ,WARE HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM . , United Kingdom
Manufacturer Name
Glaxo Operations UK Limited
Manufacturer Country
UNITED KINGDOM
Approval Date
2023-04-26
Expiry Date
2028-04-25